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Abstract
Aims: The Symphony Project is designed to identify which groups of the South Somerset population in England would most benefit from
greater integration across primary, community, acute and social care settings.
Methods:We analysed linked health and social care data for the entire South Somerset population for the financial year 2012/2013. The
data captured acute, primary, community, mental health and social care utilisation and costs; demographic characteristics; and indicators of
morbidity for each individual. We employed generalized linear models to analyse variation in annual health and social care costs for all
114,874 members of the South Somerset population and for 1458 individuals with three or more selected chronic conditions.
Results: We found that multi-morbidity, not age, was the key driver of health and social care costs. Moreover, the number of chronic
conditions is as useful as information about specific conditions at predicting costs. We are able to explain 7% of the variation in total
annual costs for population as a whole, and 14% of the variation for those with three or more conditions. We are best able to explain pri-
mary care costs, but explanatory power is poor for mental health and social care costs.
Conclusions: The linked dataset makes it possible to understand existing patterns of health and social care utilisation and to analyse
variation in annual costs, for the whole population and for sub-groups, in total and by setting. This has made it possible to identify
who would most benefit from improved integrated care and to calculate capitated budgets to support financial integration.
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Introduction
Since the inception of the NHS, an ever-present challenge has been to improve integration of care within the health care
system and with social care [1]. Many people have complex and ongoing care needs and require support from multiple
agencies and various professionals [2]. But care is often fragmented and uncoordinated, with no one agency taking
overall responsibility, so it is often left to individuals and their families to negotiate the system as best they can [3].
Traditionally, in England, health and social care funds have been channelled to institutions not individuals. In many
instances, institutionally based funding fails to recognise that many people, particularly those with combinations of
conditions, move across institutions, receiving care in multiple settings. But this creates problems. Patients find it dif-
ficult to negotiate their way through the health and care system. Care providers have had little financial incentive and
have lacked financial mechanisms to allow funding to follow patients as they move from one setting to another. It has
been recognised that financial arrangements need to be revised so as to support rather than inhibit organisations to
work collaboratively around the needs of patients [4].
Over the last 15 years, the English government has taken several steps to improve the integration of health and social
care in England. Statutory measures include the financial flexibilities (e.g. for pooling health and social care funds) first
introduced in the 1999 Health Act and the introduction of Care Trusts which combined health and social care respon-
sibilities within single NHS organisations. More recently, the Better Care Fund (formerly, the Integration Transformation
Fund) has been proposed to support radical changes across the health and social care system by pooling funds of
£3.8 billion [5], though this has proved controversial [6]. There have also been experimental projects, such as the
Integrated Care Pilots (ICPs), the Partnerships for Older People Projects pilots and various local initiatives [7–8].
In a similar vein, in South Somerset, the county council, district hospital, community provider and clinical commis-
sioning group have set up the Symphony Project to develop a tailored package of integrated care, centred on the
needs of individual patients, particularly those with complex conditions. Somerset has a history of joint working;
indeed, the Somerset Health and Social Care Trust was the first care trust to be set up in England [9]. Extending
this tradition, the Symphony Project is designed to improve collaboration across primary, community, mental health,
acute and social care. Collaborative working recognises joint responsibility by all organisations to deliver shared out-
comes and is to be incentivised by linked financial arrangements.
To be able to realise these ambitions, the Symphony Project needs to be targeted initially at a subset of the popula-
tion who would be expected to benefit most from integrated care. In what follows, we describe the process adopted
to identify this initial group.
Data and methods
The analytical objective of the Symphony Project was to identify which people might comprise the initial group to
which integrated care arrangements would apply. Various methods to identify eligible groups have been used in
other contexts. For example, the ICPs used methods including risk profiling tools and clinical judgement to target
those at higher risk of hospital unplanned admission (Norfolk); presence in local general practitioners’ (GPs) demen-
tia register (Newquay); reviewing of medical records to identify patients at risk of falling (North Tyneside); and iden-
tification of patients with moderate or severe chronic obstructive pulmonary disease (COPD) based on past
hospitalisation or exacerbations of poor lung function (Northumbria) [10]. In the USA, Medicaid eligibility criteria
and criteria for nursing home admission – e.g. significant functional problems and several chronic conditions –
have been used [11].
We developed four broad criteria to identify groups most suitable for pooled funding arrangements that might facil-
itate integrated care [12]. First, to support financial integration, the number in the group needs to form a sufficiently
large and stable “risk pool”. This should allow clear identification of who belongs to the group and ensure that those
with high costs are offset by those with low costs. Second, to realise savings, initial focus should be directed towards
those patients who are expected to be the highest users of services. We base expectations on current patterns of
activity and cost [13–14]. Third, those using services across diverse settings are more likely to benefit from inte-
grated care, simply because they are currently more likely to be subject to fragmented provision and duplication.
Fourth, there should be local consensus that changes to the care pathway are feasible.
We assessed the first three of these criteria by examining patterns of health and social care utilisation and costs for
South Somerset’s entire population of 114,874 people in the financial year from March 2012 to April 2013. The
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Symphony Project has built a large data set comprising information about each anonymised individual in the South
Somerset population. The data set has four key features: (i) it links acute, primary care, community, mental health
and social care utilisation and activity data at individual level; (ii) costs are assigned to each individual according
to the type of care they have received in each setting; (iii) demographic characteristics are available for each indivi-
dual, including age, gender and socio-economic indicators; and (iv) critically, the data set includes indicators of mor-
bidity for each individual.
Describing morbidity
Each individual’s morbidity profile is constructed using United Health’s RISC tool [15]. RISC is a patient-level predic-
tive modelling tool developed by United Health, UK, to assess the risk of patients having unplanned hospital admis-
sions within a 12-month period. The tool utilises diagnostic information, described using ICD10 [16] and Read codes
[17], in the patient’s GP and hospital records. Chronic conditions are identified if the relevant diagnostic information
appears in their GP record at any time in their medical history. The diagnostic information is summarised into 586
Episode Treatment Groups (ETGs) and 15 priority conditions, which are listed in the spreadsheet in the online
appendix. Forty-nine of these ETGs and priority conditions are indicative of chronic conditions, and these formed
the basis for describing the morbidity profile of each individual in the population. Individuals can, of course, have mul-
tiple chronic conditions.
We presented details of multi-morbidity profiles for those with particular conditions at a workshop with local health
and social care professionals and managers in South Somerset [12]. Following this workshop, further analyses
were conducted for those with at least three of a limited set of eight chronic conditions that local GPs viewed as
most significant. These conditions were as follows: diabetes, cardiac disease, COPD or OPD, chronic kidney dis-
ease (CKD) or renal failure, depression or anxiety, dementia, stroke and cancer. In what follows we refer to the group
with three or more of these conditions as the 3+ group.
Utilisation and costs
For each member of the population, utilisation and costs were described in each setting of care. Primary care cap-
tures patient interaction with their general practice, including face-to-face contacts, telephone consultations and pre-
scribing. Total primary care costs were allocated to each patient on the basis of the number of contacts they had
during the year. Prescribing utilisation was captured by the RISC tool with the total local prescribing budget allocated
to individuals according to the number of unique prescriptions received during the year. Acute and community care
utilisation was based on activity information sourced through the NHS Secondary Uses Service including the num-
ber, type and length of episodes. Costs were based on the national tariffs associated with the particular Healthcare
Resource Group [18] to which each patient was assigned. Mental health utilisation was based on nationally defined
‘mental health clusters’ [19], with costs calculated by Somerset Partnership, the local provider of mental health ser-
vices. Social care utilisation was based on activity and cost information provided by Somerset County Council,
including utilisation of home care, residential placements, day care, professional services, direct support and provi-
sion of equipment. Continuing care was based on activity and cost information provided by the local Continuing
Healthcare team.
Analytical model
We applied multiple regression models to analyse each person’s total costs and costs incurred in each of the eight
settings. We conducted the analysis for the whole population and for the 3+ group.
While most people had some form of primary care contact during the year, many people utilised no care in inpatient,
outpatient, accident and emergency (A&E), mental health, community care, social care and continuing care settings.
Consequently, to analyse costs in such settings, we employ two-part models [20–22] which allowed us to account for
the large number of zeros found in the data. The two parts are assumed to be independent and can be estimated
separately. The first part, estimated by a logistic regression, models the probability of incurring any expenditure,
and the second part models the amount of expenditure only for those with positive costs. Primary care costs and total
costs for the 3+ group exhibit a very small proportion of zeros and are estimated with a single model.
To model positive costs, we compared a generalised linear model (GLM) with log link and gamma distributed errors
[23–25] with a log-linear regression model where costs are logarithmically transformed to reduce skewness and
International Journal of Integrated Care – Volume 15, 28 January – URN:NBN:NL:UI:10-1-114806 – http://www.ijic.org/
This article is published in a peer reviewed section of the International Journal of Integrated Care 3
normalise the distribution. When the error term in the log transformation model is not normal, the non-parametric Duan
smearing estimator [20] is usually applied under the assumption of homoscedasticity: the exponentiated linear predic-
tor is multiplied by a smearing factor which is calculated as the average of the exponentiated least squares residuals.
We compare GLM and log-linear model performance in terms of R2 (of the regression of costs on predicted costs on
the raw scale), Root Mean Square Error, and Mean Absolute Prediction Error. As shown in Table 1, the GLM model
performed better in all settings with the exception of mental health, so we focus on these GLM results in what follows.
Our set of explanatory variables included gender, the percentage of people in income deprivation in the local area,
indicators for whether the individual died during the course of the year or moved elsewhere, the number (and square)
of all chronic conditions, eight binary comorbidity variables indicating whether or not a person has one of the limited
set of eight chronic conditions and two continuous age variables (age_p1 and age_p2) that capture the effects of age
on costs for people younger than 55 and older than 55 years. This age specification is motivated by Figure 1 which
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Figure 1. Average costs by age group.
Table 1. Measures of performance for the log-linear model (LLM) and generalised linear model (GLM) – 3+ group
R2 RMSE MAPE
LLM GLM LLM GLM LLM GLM
Total 0.110 0.136 12,593 11,490 6838 6282
PC 0.233 0.239 387 383 296 292
IP 0.132 0.147 4960 4806 3428 3337
OP 0.172 0.173 498 498 353 353
A&E 0.120 0.127 188 187 120 120
CM 0.050 0.101 11,380 7657 7709 5567
MH 0.041 0.021 13,246 14,710 4109 4640
SC 0.107 0.113 6732 6712 4265 4289
CC 0.128 0.339 14,914 13,644 7190 6255
PC, primary care; IP, inpatient; OP, outpatient: A&E, accident and emergency; CM, community care; MH, mental health care; SC, social care; CC, continuing care; RMSE, Root mean
square error; MAPE, Mean absolute prediction error.
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plots average costs for the South Somerset population by 5-year age bands: age appears to be a piecewise relation-
ship of costs with a segment for people younger than 55 years for whom costs vary little with age and another seg-
ment for people above 55 years old whose costs increase ever more steeply with age. As in other studies [13–22],
we account for socio-economic circumstances by using the income deprivation domain of the English Index of Multi-
ple Deprivation (IMD 2010), which measures the proportion of the population in each person’s residential area that
lives in income-deprived families. We use the data available at Lower Super Output Area (LSOA) level – the smallest
geographical area in England for which deprivation information is collected [26].
Results
Table 2 summarises the characteristics of the whole Somerset population of 114,874 people (columns 1 and 2) and
of the subset of 1458 people with three or more of the eight chronic conditions, namely the 3+ group (columns 3 and
4). The 3+ group are more likely to be male and older (53% and 78 years) than the whole population (49% and 43
years). More than 11% of the 3+ group died during the course of the year compared to less than 1% in the whole
population, and a smaller proportion (under 1%) moved out of the area (3% for the whole population). The percen-
tage living in income deprivation is about the same in the two groups (10%). The average person in the 3+ group has
16 conditions (i.e. ETGs) and 5 of the 49 chronic conditions – the numbers for the whole population are 4 and 1.
Table 3 summarises annual utilisation and costs according to the type of health and social care for the South Som-
erset population as a whole (columns 1 and 2) and for the 3+ group (columns 3 and 4) for the full financial year 2012/
2013. About two-thirds of the population and almost everyone in the 3+ group received prescribed medication.
Almost four-fifths of the population and all but 4 patients in the 3+ group had a contact with their GP. Much smaller
proportions of people in the 3+ group incurred costs in the other settings: 65% had an inpatient admission (15% in
the population), 9% utilised community care (less than 2% in the population), 12% received mental health care
(1.5% in the population), 31% had social care costs (less than 3% in the population) and about 9% had continuing
care costs (just over 0.5% in the population).
For those who incurred costs in South Somerset, the average cost of care amounted to £1227, but there was wide
variation in costs, with some people incurring high costs, reaching £17,830 at the 99th centile. The average total cost
of care was significantly (p < 0.001) higher in the 3+ group at £8163. Average inpatient costs were also higher for the
3+ group reaching £4842 compared to £2549 for the population. Average annual costs for the 3+ group are signifi-
cantly higher than for the general population in primary care, acute and community health care settings, but continu-
ing care costs are lower (p = 0.04). Average annual mental health and social care costs are quite similar.
The older that people are, the more the conditions they have. This is illustrated in Figure 2 which plots the number of
chronic conditions by 5-year age bands for the full population. At the extremes, fewer than 20% of those aged 0–4
have 1 or more chronic conditions while almost 50% of those aged 85+ have three or more chronic conditions.
We disentangled the relative contributions that age and the number of conditions have on costs. When we consid-
ered age by itself, it was able to explain only 6% of the variation in cost among the population. When we considered
only the number of chronic conditions, these explained about 10% of the variation in costs among individuals. Includ-
ing age alongside the number of chronic conditions added little explanatory power, R2 increasing by only 0.5%.
Table 2. Summary statistics – background variables
(1) (2) (3) (4)
Population (N = 114,874) 3+ group (N = 1458)
% Mean % mean
Male 48.93 52.67
Died 0.90 11.59
Moved elsewhere 2.66 0.89
Age 42.65 77.50
% in income deprivation in LSOA 9.76 10.19
Number of conditions 4.03 16.03
Number of chronic conditions 0.94 5.47
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Figure 3 shows the prevalence and costs associated with combinations of conditions among the 3+ group. The aver-
age annual cost of £8152 for all 1458 people in this group is indicated by the dashed circle. Costs vary from the aver-
age according to particular conditions. Most notably, costs are about £14,000 if dementia is among the conditions
and £12,000 if CKD/renal is a co-morbidity, but there is little difference to the overall average for the other conditions.
We applied our GLM regression model to explain variation in positive costs (i.e. after excluding those with zero costs)
in each setting for the full population (Table 4) and for the 3+ group (Table 5). Explanatory power, as indicated by the
R2 from the regression of actual costs on the predicted scores on the raw scale, varies markedly by setting. The
model explains 7% of variation in total costs for the full population and 14% for the 3+ group. Explanatory power
is highest when explaining primary care costs, this being the setting in which most people were seen at least
once during the year. At the other extreme, the model is able to explain very little of the variation in mental health
care costs, whether for the full population or the 3+ group.
The specific factors that explain costs differ between the full population and the 3+ group and according to the setting
under consideration. For the full population, costs increase significantly with age, but for the 3+ group age was posi-
tively associated only with community care costs for those under 55. In the general population, men have lower total,
primary care and social care costs, but this is true only for social care costs among the 3+ group. Those among the
whole population living in more deprived areas had higher total, primary care and A&E costs, but deprivation was not
Table 3. Summary statistics – utilisation per person and average costs (£), 2012–2013
(1) (2) (3) (4) (5)
Population (N = 114,874) 3+ group (N = 1458) t-test
% utilising Av costs* (£) % utilising Av costs* (£) p-value***
Primary care 81.70 241 99.73 895 <0.001
Prescriptions 66.08 194 99.66 631 <0.001
GP 78.92 87 99.73 264 <0.001
Acute 37.80 1339 85.80 4269 <0.001
Inpatient 14.90 2549 64.81 4842 <0.001
Outpatient 30.19 351 71.81 567 <0.001
A&E 13.77 148 48.90 239 <0.001
Community 1.64 2158 9.05 7476 <0.001
Inpatient 0.36 9556 7.34 9194 0.63
Outpatient 0.33 181 0.62 174 0.80
A&E 0.99 79 1.17 89 0.59
Mental health 1.51 4633 12.07 3922 0.42
Social care 2.64 5684 31.48 5622 0.88
Home care 0.69 3359 12.35 3000 0.20
Placement 0.77 9887 10.43 9065 0.42
Day care 0.20 3981 2.13 1565 <0.001
Direct pay 0.19 7064 0.96 4449 0.18
Equipment 0.87 183 10.63 186 0.90
Other services 0.04 2684 0
Professional support 2.64 1140 31.48 1140
Continuing care 0.58 11,529 8.71 7773 0.04
CHC nursing home 0.34 4160 5.21 4152 0.97
Funding for home care 0.27 19,983 3.77 12,211 0.04
Total 83.57 1227 99.86 8163 <0.001
Total** 1026 8152 <0.001
*average costs calculated averaging over those with positive costs; **average total costs calculated averaging over the whole sample; ***p-values of independent t-tests comparing
costs for those with positive costs in the 3+ group and the rest of population.
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significantly associated with higher costs in other settings, nor in any setting for the 3+ group (except outpatient at
p < 0.01). The number of chronic conditions is an important predictor of higher costs for the whole population in
all settings except mental health, social and continuing care. The average person in the 3+ group had five chronic
conditions, and increasing the number of conditions above this average explains higher costs only in primary care.
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Figure 3. Average costs by co-morbidity for the 3+ conditions group.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Pa
e
nt
s
Age band (years)
Multi-morbidity by age band
0
1
2
3
4
5
6
7+
Number of
conditions
Figure 2. Relationship between age and the number of chronic conditions (ETGs).
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People who move into or out of the area during the year had higher primary care costs but lower outpatient and con-
tinuing care costs (Table 4), but migration is not significant in explaining costs among the 3+ group (Table 5). Those
among the general population who died during the year had significantly higher costs in primary and acute care set-
tings although continuing care costs are significantly lower. Among the 3+ group, those who died had higher total,
primary care and inpatient costs, but lower outpatient and continuing care costs.
Whether someone had one of the eight specific conditions does not necessarily mean that their costs will be higher,
with the coefficients often proving non-significant, particularly among the 3+ group (Table 5). For the whole popula-
tion (Table 4), those with dementia had higher total annual costs than those without such diagnoses. For the 3+
group (Table 5), total annual costs were higher for those with CKD/renal and dementia. For CKD/renal, costs were
higher in primary and inpatient settings; those with dementia had higher social care costs.
Discussion and conclusion
The purpose of this study was to identify groups most suitable for pooled funding arrangements that might facilitate
integrated care. Analysis was performed using linked health and social care data for the entire South Somerset
population for the financial year 2012/2013. The data captured acute, primary care, community, mental health and
social care utilisation and costs; demographic characteristics; and indicators of morbidity for each individual in the
population. The analysis demonstrated that multi-morbidity, not age, was the key driver of health and social care
costs. While costs were positively associated with age, accounting for age adds little explanatory power once we
have accounted for the number of conditions in analysing costs.
The ability to measure morbidity is a significant advantage over studies that lack such information and are forced,
instead, to rely on other variables to explain variation in costs. In their review of the literature, Zweifel et al. find
that age and other socio-demographic information explain no more than 5% of the variation in health care costs;
past utilisation increases explanatory power by around 1–2%, but the inclusion of information about morbidity
adds more than 7% to explanatory power [27]. Similarly, Dixon et al. find that 12% of variation in costs is explained
Table 4. Influence of characteristics in explaining positive costs for the whole population
Total PC IP OP A&E CM MH SC CC
(N =
96,005)
(N =
93,851)
(N =
17,111)
(N =
34,686)
(N =
15,814)
(N =
1889)
(N =
1735)
(N =
3035)
(N =
670)
Age <55 0.000 0.007*** 0.003*** 0.000 −0.002*** 0.018*** 0.007 −0.025*** −0.030*
Age >= 55 0.018*** 0.016*** 0.000 −0.005*** −0.002** 0.093*** −0.030*** 0.003 −0.018**
Male −0.152*** −0.202*** −0.001 −0.006 0.018 −0.170 0.189 −0.194*** −0.050
Deprivation 0.013*** 0.009*** −0.002 0.000 0.006*** 0.013 0.020 0.005 0.003
No. of chronic cond 0.663*** 0.505*** 0.098*** 0.167*** 0.136*** 0.404*** 0.120 −0.087* 0.026
(No. of chronic cond)2 −0.045*** −0.039*** −0.001 −0.008*** −0.001 −0.020* 0.007 0.003 −0.014
Moved 0.085 0.150*** 0.051 −0.183*** 0.058 0.945 0.560 −0.020 −2.059**
Died 1.670*** 0.650*** 0.743*** 0.024 0.384*** 0.719** −0.135 0.030 −0.638***
Diabetes −0.076 0.293*** −0.038 0.053** −0.115*** −0.160 0.095 0.170* −0.081
Stroke 0.229* −0.030 0.106** −0.045 0.028 0.950*** −0.243 0.310*** 0.039
Cardiac 0.131 0.155*** 0.232*** 0.031 0.008 −0.184 −0.179 0.116 0.134
COPD/OPD+ 0.028 0.249*** 0.035 0.019 0.069* −0.346 0.028 −0.068 −0.251
CKD/Renal 0.485* 0.075* 0.433*** 0.294*** 0.121** 0.180 −0.873 0.027 −0.316
Cancer 0.085 −0.203*** 0.185*** 0.332*** −0.096*** −0.623** −0.346 −0.115 0.001
Dementia 1.407*** −0.132*** 0.091 −0.315*** 0.020 0.245 −0.243 0.577*** 0.758***
Depression −0.075 −0.027* −0.076* −0.060*** 0.040* −0.281 −0.163 0.098 0.057
R2 0.073 0.452 0.108 0.098 0.137 0.188 0.024 0.042 0.215
PC, primary care; IP, inpatient; OP, outpatient: A&E, accident and emergency; CM, community care; MH, mental health care; SC, social care; CC, continuing care
+COPD, chronic obstructive pulmonary disease; OPD, occupational pulmonary disease; CKD, chronic kidney disease.
*p < 0.05; **p < 0.01; ***p < 0.001.
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by morbidity characteristics [28]. Other studies have argued that proximity to death is a strong predictor of costs
[29–32] but only in the absence of information about patient morbidity, which proves the more important explanatory
factor [33].
In our study, we find that the number of chronic conditions that a person has is generally as important a predictor of
costs as their specific conditions. This has been found previously in examining primary care costs [34], but we reach
similar conclusions for costs in other health and social care settings. This is an important finding, because it reduces
the information requirements for the design and calculation of capitated budgets to support integrated care, allowing
budgets to be constructed in localities that are able to count the number of conditions a person has but that lack the
detailed morbidity data available for the South Somerset population.
Integrated care is considered particularly important for the frail elderly [35], but identifying such people is challenging
because of the difficultly in defining and measuring frailty using routine data [36–37]. Instead, the Symphony Project
decided that the group of people most appropriate for integrated care arrangements should comprise those with
three or more conditions from a set of eight chronic conditions deemed most important by local GPs. The main rea-
sons for selecting this group were:
(1) This group of around 1500 patients offered a reasonably high level of predictable cost variation, providing a sufficiently large
risk pool for financial management;
(2) The group incurred costs across all settings, thereby offering the prospect of strengthening links across health, mental health
and social care;
(3) There is an opportunity to reduce inpatient costs, which currently account for 38% of total costs for this group.
The ambition in South Somerset is to develop integrated care arrangements initially for the cohort of people 3+
chronic conditions, through the development of personalised care planning and supported self-management. The
hope is then to extend arrangements to a larger cohort including all patients with long-term conditions.
The data set has been a key part of the foundations on which integrated care is being developed in South Somerset.
In many parts of England, health and social care data are not brought together into a single data set and, in those
areas where utilisation data have been joined together, information on costs and morbidity is lacking. The linked
Table 5. Influence of characteristics in explaining positive costs for those with 3+ conditions
Total PC IP OP A&E CM MH SC CC
(N = 1458) (N = 1458) (N = 945) (N = 1047) (N = 713) (N = 132) (N = 176) (N = 459) (N = 127)
Age < 55 −0.036 0.002 −0.049* −0.021 −0.017 0.155*** 0.182 −0.005 1.290**
Age ≥55 0.006 −0.002 −0.006 −0.023*** −0.004 0.013 −0.026 0.009 −0.027*
Male −0.004 0.015 0.086 0.127* 0.050 −0.107 0.501 −0.371*** −0.075
Deprivation −0.001 0.001 −0.004 −0.016** 0.003 −0.006 0.024 0.002 −0.045
No. of chronic cond 0.308** 0.192*** 0.004 0.154 0.150 0.090 −0.397 −0.009 −0.820
(No. of chronic cond)2 −0.008 −0.006* 0.011 −0.004 −0.001 −0.003 0.049 0.000 0.057
Moved 0.412 −0.193 0.490 −0.085 −0.021 0.134 1.865 0.067 −1.385
Died 0.639*** 0.112** 0.583*** −0.300*** 0.164* 0.042 0.222 −0.055 −0.687**
Diabetes −0.068 0.049 −0.150 −0.102 −0.145* −0.218 0.262 0.213 0.168
Stroke 0.145 −0.036 −0.049 −0.199** −0.028 0.335 0.541 0.429** −0.116
Cardiac −0.022 0.049 0.010 −0.072 0.036 −0.330 −0.019 −0.006 0.236
COPD/OPD+ −0.087 0.099** −0.102 −0.137 0.060 0.134 −0.034 0.042 −0.122
CKD/Renal 0.394*** 0.096** 0.313*** 0.199* 0.179* 0.296 −1.028* 0.094 −0.283
Cancer −0.115 −0.088** 0.015 0.121 −0.031 −0.320 0.200 −0.145 −0.076
Dementia 0.727*** −0.084* −0.008 −0.440*** −0.038 0.128 −0.537 0.617*** 0.724*
Depression −0.159 −0.080* −0.189* −0.173* −0.030 −0.010 −0.215 0.097 −0.006
R2 0.136 0.239 0.147 0.173 0.127 0.101 0.021 0.113 0.345
PC, primary care; IP, inpatient; OP, outpatient: A&E, accident and emergency; CM, community care; MH, mental health care; SC, social care; CC, continuing care.
+COPD, chronic obstructive pulmonary disease; OPD, occupational pulmonary disease; CKD, chronic kidney disease.
*p < 0.05; **p < 0.01; ***p < 0.001.
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data have made it possible to understand existing patterns of health and social care utilisation and to analyse varia-
tion in annual costs, for the population as a whole and for members of the 3+ group, in total and by setting. In terms of
each setting, our model performs best at explaining primary care costs, but explanatory power is poor when it comes
to explaining mental health and social care costs, so further research is required to identify drivers of costs in these
settings.
The data make it possible to calculate capitated budgets for different groups of the population, informed by current
patterns of utilisation, and to use the model parameters to refine predictions of budgetary requirements, should the
compositional characteristics of the group change or if there are changes across the settings in which care delivery
takes place.
A drawback is that we have analysed only a single years’ worth of data, which means that we can identify only asso-
ciations not causal relations between costs and the explanatory factors. This is true of all cross-sectional studies,
although our data have the advantage that chronic conditions are identified if they have ever appeared in the
patient’s medical history, not just in the year in question.
The data are also from a relatively small locality, which limits generalisability of the results. However, the methods are
generally applicable and, by demonstrating that the analytical approach can be applied to a small area, we believe
that these methods can support local attempts to introduce integrated financial arrangements. Moreover, by main-
taining the data set year on year, it will be possible to assess whether the efforts made to improve integrated care
for the local population of South Somerset succeed in realising the ambition of the Symphony Project.
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